查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529772

半固态药物契约製造市场规模、份额、趋势分析报告：按类型、产品、最终用途、公司规模、地区、细分市场预测，2024-2030年

Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

市场规模及趋势

预计2023年全球半固态药品契约製造市场规模为175.7亿美元，预计2024年至2030年复合年增长率为11.12%。对患者友善药物的需求不断增长，加上皮肤病、关节炎和疼痛管理等慢性疾病的盛行率不断上升，正在推动市场成长。此外，由于其成本效益，对製造外包的需求正在增加。此外，监管合规性和品质保证、技术进步（包括配方技术创新）可能会在预测期内推动需求。

皮肤病、关节炎等慢性病的高盛行率以及由于世界老化而对疼痛管理解决方案的需求是市场成长的主要驱动力。根据世界卫生组织 (WHO) 统计，估计有 18 亿人在任何特定时间都患有 3,000 多种皮肤病，对有效治疗的需求庞大。美国人口正在快速老化。根据人口研究所2024年1月发布的情况说明书，65岁及以上的美国人数量将从2022年的5800万跃升至2050年的8200万，大幅增长47%。此外，65岁及以上人口占总人口的比例预计将从17%上升至23%，成为美国历史上最古老的年龄分布。

此外，根据2021年全球疾病负担研究，皮肤病在全球健康负担中排名第8。固态製剂，例如乳霜剂和软膏，是许多皮肤状况的首选给药方法，并且涂布、温和。随着製药公司寻求具有专业知识的合作伙伴来高效、大量生产这些药物，对皮肤病和疼痛管理治疗的需求激增正在推动市场成长。此外，根据 CDC 2019 年至 2021 年期间的报告，关节炎是美国最常见的疾病，影响 17.9% 的男性和 24.2% 的女性 (NHIS)。

此外，契约製造允许製药公司利用製造能力，遵守监管标准，并获得支援以最大限度地降低与内部製造设施相关的成本。製药公司和契约製造製造商之间的策略联盟有助于高效生产半固态製剂，促进快速进入市场和优化现有製剂。建立和维护半固态製剂的内部生产线需要大量投资。这包括混合、填充和包装这些剂型的专用设备，以及有效操作它们的专业知识。透过与契约製造製造商 (CMO) 合作，製药公司可以避免这些前期成本和持续的维护成本。 CMO 专注于半固态药品的製造，并具有规模经济，使他们能够利用其专业知识和设备为多个客户服务。

由于配方技术的进步和对以患者为中心的解决方案日益浓厚的兴趣，半固态配方的契约製造市场正在经历创新发展的激增。配方创新包括使用奈米和微粉化颗粒来提高生物有效性，以及使用先进的粒度分布技术来优化稳定性和性能。製药公司也优先考虑患者的依从性，并引入易于使用的包装设计和自我管理功能。製药公司和契约製造製造商之间的策略联盟能够实现这些特种配方的高效生产和快速市场进入。

儘管市场主要是由对药用霜剂、软膏和凝胶的需求不断增长推动的，但 CMO 也可以利用他们在这些半固态配方方面的专业知识来满足化妆品行业的需求。这使您能够扩大基本客群并优化您的生产线。此外，消费者对外用护肤品的兴趣日益浓厚，为 CMO 与化妆品公司合作开发和製造创新乳霜、精华液和乳液创造了更多机会。製药和化妆品领域之间的这种协同效应正在推动整体市场的成长。

此外，对个人化医疗的需求正在刺激针对个人需求的客製化固态剂型的开发。吸收增强成分和新型赋形剂也被用来提高这些局部治疗的功效和生物有效性。这些多方面的创新正在改变半固态药物市场，为各种皮肤、眼睛和慢性疼痛病症提供更有效、更方便和个人化的解决方案。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 半固态药物契约製造市场的变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 半固态药物契约製造市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章半固态药品契约製造市场：按类型估计和趋势分析

  • 市场占有率：依类型划分，2023/2030
  • 细分仪表板
  • 全球半固态药物契约製造市场前景：按类型
  • 2018-2030年市场规模及预测及趋势分析
  • 局部的
  • 经皮的
  • 口服

第五章 半固态药物契约製造市场：依产品估价及趋势分析

  • 市场占有率：依产品划分，2023/2030
  • 细分仪表板
  • 全球半固态药物契约製造市场展望：依产品分类
  • 2018-2030年市场规模及预测及趋势分析
  • 奶油
  • 软膏
  • 凝胶
  • 洗剂
  • 贴上
  • 其他的

第六章 半固态药物契约製造市场：依最终用途分类的估计与趋势分析

  • 市场占有率：最终用途，2023/2030
  • 细分仪表板
  • 全球半固态药品契约製造市场展望：依最终用途分类
  • 2018-2030年市场规模及预测及趋势分析
  • 製药公司
  • 化妆品公司
  • 其他的

第七章 半固态药物契约製造市场：依公司规模估算与趋势分析

  • 市场占有率：依公司规模划分，2023/2030
  • 细分仪表板
  • 全球半固态药品契约製造市场前景：依公司规模划分
  • 2018-2030年市场规模及预测及趋势分析
  • 大型企业
  • 中型企业/中小企业
  • 其他的

第八章 半固态药品契约製造市场：区域估计和趋势分析

  • 市场占有率分析：按地区划分，2023 年和 2030 年
  • 市场仪表板：按地区
  • 2018-2030年市场规模及预测及趋势分析：
  • 北美洲
    • 2018-2030 年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030 年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲市场估计和预测：2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
  • 公司简介
    • Lonza Group Ltd.
    • Lubrizol Life Science
    • Cambrex Corporation
    • Contract Pharmaceuticals Limited
    • Bora Pharmaceutical CDMO
    • Ascendia Pharmaceuticals
    • Pierre Fabre group
    • Piramal Pharma Solutions
    • DPT Laboratories, LTD
    • MedPharm Ltd
    • Catalent, Inc.
    • Recipharm AB
    • Aenova Group
    • Almac Group
    • Ajinomoto Bio-Pharma Services
Product Code: GVR-4-68040-345-3

Market Size & Trends

The global semi-solid dosage contract manufacturing market size was valued at USD 17.57 billion in 2023 and is projected to grow at a CAGR of 11.12% from 2024 to 2030. The rising demand for patient-friendly medications coupled with growing prevalence of chronic diseases such as skin diseases, arthritis, and pain management aids the market growth. Moreover, there is a growing demand for manufacturing outsourcing due to its cost-effectiveness. Furthermore, regulatory compliance and quality assurance, technological advancements including innovation in formulation technologies, are likely to boost their demand over the forecast period.

The high prevalence of chronic conditions such as skin diseases, arthritis and the requirement for pain management solutions due to the ageing population around the world is a major factor for the market growth. With an estimated 1.8 billion people affected by over 3,000 types of skin conditions at any given time, according to the World Health Organization, there's a massive demand for effective treatments. The U.S. population is experiencing a significant shift towards aging. According to the January 2024 fact sheet by the Population Reference Bureau, the number of Americans aged 65 and older is expected to surge from 58 million in 2022 to 82 million by 2050, representing a substantial 47% increase. Additionally, the proportion of the total population comprised of individuals aged 65 and older is projected to rise from 17% to 23%, marking the oldest age distribution in U.S. history.

In addition, according to the Global Burden of Disease Study 2021, skin diseases rank as the eighth leading cause of global health burden. Semi-solid dosage forms, such as creams and ointments, are a preferred method of administration for many skin diseases, offering a convenient and mess-free application. This surge in demand for skin condition and pain management treatments is propelling the growth of the market, as pharmaceutical companies seek out partners with the expertise to produce these medications efficiently and in large quantities. Further, according to the CDC report covering the period from 2019 to 2021, arthritis was most prevalent in 17.9% of men and 24.2% of women in the U.S. (NHIS).

Additionally, contract manufacturing enables pharmaceutical companies to access manufacturing capabilities, adhere to regulatory standards, and support to minimize costs associated with in-house production facilities. Strategic collaborations between pharmaceutical companies and contract manufacturers are instrumental in the efficient production of semi solid dosage forms, facilitating faster market entry for drugs further optimization of existing formulations. Setting up and maintaining in-house production lines for semi-solid medications requires substantial investments. This includes specialized equipment for mixing, filling, and packaging these dosage forms, as well as the expertise to operate them efficiently. By partnering with a contract manufacturer (CMO), pharmaceutical companies can bypass these upfront costs and ongoing maintenance expenses. CMOs specialize in semi-solid production and have economies of scale, allowing them to leverage their expertise and equipment for multiple clients.

The semi-solid dosage contract manufacturing market is witnessing a surge of innovative developments, driven by advancements in formulation technology and a growing focus on patient-centric solutions. Formulation innovations include the use of nano and micronized particles to enhance bioavailability, as well as sophisticated particle size distribution techniques to optimize stability and performance. Manufacturers are also prioritizing patient compliance, with the introduction of user-friendly packaging designs and self-administration features. Strategic collaborations between pharmaceutical companies and contract manufacturers are enabling efficient production and faster market entry of these specialized formulations.

While the market is primarily driven by the growing demand for pharmaceutical creams, ointments, and gels, CMOs can leverage their expertise in these semi-solid dosage forms to cater to the cosmetics industry as well. This allows them to expand their client base and optimize production lines. Furthermore, the growing consumer interest in topical skincare products creates additional opportunities for CMOs to partner with cosmetic companies in developing and manufacturing innovative creams, serums, and lotions. This synergy between the pharmaceutical and cosmetic sector helps to fuel the overall growth of the market.

Furthermore, the demand for personalized medicine is fueling the development of customized semi-solid dosage forms tailored to individual needs. Absorption-enhancing ingredients and novel excipients are also being leveraged to improve the efficacy and bioavailability of these topical treatments. These multifaceted innovations are transforming the semi-solid dosage form market, offering more effective, convenient, and personalized solutions for a wide range of skin, eye, and chronic pain conditions.

Global Semi-solid Dosage Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global semi-solid dosage contract manufacturing market report on the basis of type, product, end use, company size and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Topical
  • Transdermal
  • Oral
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Creams
  • Ointments
  • Gels
  • Lotions
  • Pastes
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Cosmeceutical Companies
  • Others
  • Company Size Outlook (Revenue, USD Million, 2018 - 2030)
  • Large Size Companies
  • Medium & Small Size Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Product
    • 1.2.3. End Use
    • 1.2.4. Company Size
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Semi-solid Dosage Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for patient-friendly medications
      • 3.2.1.2. Growing prevalence of chronic diseases
      • 3.2.1.3. Growing demand of manufacturing outsourcing
      • 3.2.1.4. Regulatory Compliance
      • 3.2.1.5. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Quality control challenges
  • 3.3. Semi-solid Dosage Contract Manufacturing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Semi-solid Dosage Contract Manufacturing Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Semi-solid Dosage Contract Manufacturing Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Topical
    • 4.5.1. Topical market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Transdermal
    • 4.6.1. Transdermal market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Oral
    • 4.7.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Semi-solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 5.1. Product Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Semi-solid Dosage Contract Manufacturing Market by Product Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Creams
    • 5.5.1. Creams market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Ointments
    • 5.6.1. Ointments market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Gels
    • 5.7.1. Gels market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Lotions
    • 5.8.1. Lotions market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Pastes
    • 5.9.1. Pastes market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Other
    • 5.10.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Semi-solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Semi-solid Dosage Contract Manufacturing Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Pharmaceutical companies
    • 6.5.1. Pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Cosmeceutical companies
    • 6.6.1. Cosmeceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Other
    • 6.7.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Semi-solid Dosage Contract Manufacturing Market: Company Size Estimates & Trend Analysis

  • 7.1. Company Size Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Semi-solid Dosage Contract Manufacturing Market by Company Size Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Large Size Companies
    • 7.5.1. Large size companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Medium & Small Size Companies
    • 7.6.1. Medium & small size companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Semi-solid Dosage Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory Scenario
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory Scenario
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory Scenario
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory Scenario
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory Scenario
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory Scenario
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory Scenario
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory Scenario
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory Scenario
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory Scenario
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory Scenario
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory Scenario
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory Scenario
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory Scenario
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory Scenario
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Regulatory framework
      • 8.8.5.3. Competitive scenario
      • 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
  • 9.4. Company Profiles
    • 9.4.1. Lonza Group Ltd.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Others benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Lubrizol Life Science
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Others benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Cambrex Corporation
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Others benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Contract Pharmaceuticals Limited
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Others benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Bora Pharmaceutical CDMO
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Others benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Ascendia Pharmaceuticals
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Others benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Pierre Fabre group
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Others benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Piramal Pharma Solutions
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Others benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. DPT Laboratories, LTD
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Others benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. MedPharm Ltd
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Others benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Catalent, Inc.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Others benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Recipharm AB
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Others benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Aenova Group
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Others benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Almac Group
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Others benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Ajinomoto Bio-Pharma Services
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Others benchmarking
      • 9.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 7 U.S. semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 11 Canada semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 15 Mexico semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 16 Mexico semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Mexico semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 19 Europe semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 24 Germany semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 28 UK semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 29 UK semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 UK semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 32 France semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 33 France semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 34 France semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 France semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 36 Italy semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 37 Italy semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Italy semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 40 Spain semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 41 Spain semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Spain semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 44 Denmark semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Denmark semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Denmark semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 48 Sweden semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 49 Sweden semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Sweden semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 52 Norway semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 53 Norway semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 54 Norway semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Norway semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 61 China semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 62 China semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 63 China semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 64 China semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 65 Japan semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 66 Japan semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Japan semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 69 India semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 70 India semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 71 India semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 India semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 73 South Korea semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 74 South Korea semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 75 South Korea semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 76 South Korea semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 77 Australia semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 78 Australia semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Australia semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 81 Thailand semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 82 Thailand semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 84 Thailand semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 85 Latin America semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 86 Latin America semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 87 Latin America semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Latin America semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 89 Brazil semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 90 Brazil semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 91 Brazil semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Brazil semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 93 Argentina semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 94 Argentina semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 95 Argentina semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 96 Argentina semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 97 MEA semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 98 MEA semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 99 MEA semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 100 MEA semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 101 MEA semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 102 South Africa semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 103 South Africa semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 105 South Africa semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 110 UAE semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 111 UAE semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 112 UAE semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 113 UAE semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 114 Kuwait semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 115 Kuwait semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Kuwait semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Semi-solid dosage contract manufacturing market: market outlook
  • Fig. 14 Semi-solid dosage contract manufacturing competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Semi-solid dosage contract manufacturing market driver impact
  • Fig. 20 Semi-solid dosage contract manufacturing market restraint impact
  • Fig. 21 Semi-solid dosage contract manufacturing market strategic initiatives analysis
  • Fig. 22 Semi-solid dosage contract manufacturing market: Type movement analysis
  • Fig. 23 Semi-solid dosage contract manufacturing market: Type outlook and key takeaways
  • Fig. 24 Topical market estimates and forecast, 2018 - 2030
  • Fig. 25 Transdermal market estimates and forecast, 2018 - 2030
  • Fig. 26 Oral market estimates and forecast, 2018 - 2030
  • Fig. 27 Semi-solid dosage contract manufacturing Market: Product movement analysis
  • Fig. 28 Semi-solid dosage contract manufacturing market: Product outlook and key takeaways
  • Fig. 29 Creams market estimates and forecasts, 2018 - 2030
  • Fig. 30 Immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 31 Ointments market estimates and forecasts, 2018 - 2030
  • Fig. 32 Gels market estimates and forecasts, 2018 - 2030
  • Fig. 33 Lotions market estimates and forecasts, 2018 - 2030
  • Fig. 34 Pastes market estimates and forecasts, 2018 - 2030
  • Fig. 35 Others market estimates and forecast, 2018 - 2030
  • Fig. 36 Semi-solid dosage contract manufacturing market: End Use movement analysis
  • Fig. 37 Semi-solid dosage contract manufacturing market: End Use outlook and key takeaways
  • Fig. 38 Pharmaceutical companies market estimates and forecast, 2018 - 2030
  • Fig. 39 Cosmeceutical companies market estimates and forecast, 2018 - 2030
  • Fig. 40 Others market estimates and forecast, 2018 - 2030
  • Fig. 41 Semi-solid dosage contract manufacturing market: End use movement analysis
  • Fig. 42 Semi-solid dosage contract manufacturing market: End use outlook and key takeaways
  • Fig. 43 Large size companies market estimates and forecasts, 2018 - 2030
  • Fig. 44 Medium & small size companies market estimates and forecasts, 2018 - 2030
  • Fig. 45 Others market estimates and forecasts, 2018 - 2030
  • Fig. 46 Global semi-solid dosage contract manufacturing market: Regional movement analysis
  • Fig. 47 Global semi-solid dosage contract manufacturing market: Regional outlook and key takeaways
  • Fig. 48 Global semi-solid dosage contract manufacturing market share and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America, by country
  • Fig. 55 North America
  • Fig. 56 North America market estimates and forecasts, 2018 - 2030
  • Fig. 57 U.S. key country dynamics
  • Fig. 58 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 59 Canada key country dynamics
  • Fig. 60 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 61 Mexico key country dynamics
  • Fig. 62 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 63 Europe
  • Fig. 64 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 65 UK key country dynamics
  • Fig. 66 UK market estimates and forecasts, 2018 - 2030
  • Fig. 67 Germany key country dynamics
  • Fig. 68 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 69 France key country dynamics
  • Fig. 70 France market estimates and forecasts, 2018 - 2030
  • Fig. 71 Italy key country dynamics
  • Fig. 72 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 73 Spain key country dynamics
  • Fig. 74 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 75 Denmark key country dynamics
  • Fig. 76 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 77 Sweden key country dynamics
  • Fig. 78 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 79 Norway key country dynamics
  • Fig. 80 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 81 Asia Pacific
  • Fig. 82 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 83 China key country dynamics
  • Fig. 84 China market estimates and forecasts, 2018 - 2030
  • Fig. 85 Japan key country dynamics
  • Fig. 86 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 87 India key country dynamics
  • Fig. 88 India market estimates and forecasts, 2018 - 2030
  • Fig. 89 Thailand key country dynamics
  • Fig. 90 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 91 South Korea key country dynamics
  • Fig. 92 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 93 Australia key country dynamics
  • Fig. 94 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 95 Latin America
  • Fig. 96 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 97 Brazil key country dynamics
  • Fig. 98 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 99 Argentina key country dynamics
  • Fig. 100 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 101 Middle East and Africa
  • Fig. 102 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 103 South Africa key country dynamics
  • Fig. 104 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 105 Saudi Arabia key country dynamics
  • Fig. 106 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 107 UAE key country dynamics
  • Fig. 108 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 109 Kuwait key country dynamics
  • Fig. 110 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 111 Market share of key market players- Semi-solid dosage contract manufacturing market